This New Drug Could Solve the GLP-1 Plateau Problem
Roche’s experimental enicepatide reduced weight without a plateau through week 48 while also improving blood sugar in adults with diabetes and obesity.
点赞
收藏
点踩
分享评论
?
参与讨论
Roche’s experimental enicepatide reduced weight without a plateau through week 48 while also improving blood sugar in adults with diabetes and obesity.